Cite
HARVARD Citation
Lim, B. et al. (n.d.). Novel combination of AR inhibitor and CDK4/6 inhibitor, MEK inhibitor in non-HR positive breast cancers. European journal of cancer. pp. S14-S15. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lim, B. et al. (n.d.). Novel combination of AR inhibitor and CDK4/6 inhibitor, MEK inhibitor in non-HR positive breast cancers. European journal of cancer. pp. S14-S15. [Online].